Cover Story

Cytek Biosciences
Cell Analysis Solutions that Accelerate Scientific Discovery

Top 10 Biotech Solution Providers

BrightInsight - Powering up the Digital Health

Biotechnology can be broadly defined as using organisms or their products for commercial purposes. Modern biotechnology, like genetic engineering, can have a dramatic effect on the world economy and society. By leveraging the possibilities of biotechnology, businesses have been trying to tap into the broader scope of technology in people's everyday lives.

Golden Helix - Leading the Charge in Clinical Variant Analysis

One of the main challenges anyone working with NGS data faces is the sheer volume of information. Finding an efficient workflow that will quickly filter through the noise and get to the clinically relevant variants is invaluable for working in this space. This is where Golden Helix—a company delivering industry-leading bioinformatics solutions—is standing apart.

Pluristem - Single Platform for Unmet Medical Needs

Cell therapeutics is a field that faces numerous challenges in the current scenario of COVID-19 and other diseases, which is undergoing continuous advancements. Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine firm that develops cell therapeutics for inflammation, muscular injuries, hematological illnesses, and radiation exposure using placental cells and a proprietary three-dimensional (3D) technology platform.

Thrive Bioscience - Biotechnology Accelerating Healthcare

Biotechnology has found millions of applications in people every day lives in the present era. The world is evolving at unprecedented rates, and no less is the pace of advancing technologies. Biotechnology is helping humans to take healthcare to a whole new perspective, and with the right support of apt technologies, we will be able to further level up the healthcare field.

MedInsights

Healthcare Revenue Cycle Management – An Entrepreneur’s Perspective

By Gary Wakeford MBA, Chief Executive Officer, SonoStik, LLC

Clinical Trial Management

Reducing the Risk of Unintentional Unblinding

By Malcolm Morrissey, Associate Director, Statistics and Product Support Services, Sylvain Berthelot, Sr. Director, Voice of the Customer and Strategy, Calyx

Clinical Trial Management

Powering Diverse and Inclusive Clinical Trials

By Dena Raffa, Senior Director, TCN Technologies, BBK Worldwide

New ground being broken in our understanding and treatment of childhood, teenage and young adult cancers

By Christiana Ogunbote, Head of Research at Children, Children with Cancer UK

Commonwealth Diagnostics International – Re-optimizing next-generation diagnostic outcomes

By Medhealth Outlook

Translate »